U.S. markets closed

Sintx Technologies, Inc. (SINT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3300-0.1500 (-10.14%)
At close: 4:00PM EDT

1.3100 -0.02 (-1.50%)
After hours: 4:27PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close1.4800
Open1.4500
Bid1.3100 x 4000
Ask1.3200 x 900
Day's Range1.2300 - 1.4700
52 Week Range0.4300 - 3.4400
Volume2,718,377
Avg. Volume4,447,304
Market Cap32.831M
Beta (5Y Monthly)2.11
PE Ratio (TTM)N/A
EPS (TTM)-1.0830
Earnings DateMar 22, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • ACCESSWIRE

    SINTX Technologies, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 30, 2021 / SINTX Technologies, Inc. (NASDAQ:SINT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 30, 2021 at 1:30 PM Eastern Time.

  • SINTX Technologies Issues 2020 10-K and Announces Investor Conference Call
    GlobeNewswire

    SINTX Technologies Issues 2020 10-K and Announces Investor Conference Call

    SALT LAKE CITY, UT, March 22, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride ceramic for medical and non-medical applications, announced today the filing of its 10-K for the year ended December 31, 2020. 2020 represented SINTX’s second full year as an advanced materials company. As COVID-19 spread and negatively impacted multiple potential opportunities, the Company was able to quickly and successfully adjust its 2020 strategic plan and capitalize on the discovery that its silicon nitride rapidly inactivates the SARS-CoV-2 virus. SINTX aggressively invested in key personnel, new collaborations with university and government laboratories, and new capital equipment. SINTX was able to engage with new partners and begin supporting their development of new antipathogenic products across a wide range of applications. SINTX is now leveraging the foundational successes of 2020 and is excited about its future. 2021 represents SINTX’s 25th year in business. SINTX plans to host a conference call to provide an update on the business. The call is scheduled for Tuesday, March 30, 2021 at 1:30 p.m. ET. The call can be accessed through dial-in: Toll-free 877-524-8416; International 412-902-1028. For those who are not available to listen to the call, a digital replay will be archived on the News & Media section of the SINTX website under Presentations. Questions will not be taken during the call. Investors and interested parties may submit questions prior to the call via email to IR@SINTX.com. Questions will be accepted through 9:00 a.m. ET, on Thursday, March 22, 2021. About SINTX Technologies, Inc.SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. The Company presently manufactures silicon nitride powders and components in its FDA registered, ISO 9001:2015 certified, ISO 13485:2016 certified, and AS9100D certified manufacturing facility. For more information on SINTX Technologies or its silicon nitride material platform, please visit www.sintx.com. Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA) that are subject to a number of risks and uncertainties. Risks and uncertainties that may cause such differences include, among other things: incorporation of silicon nitride into personal protective equipment may not be safe or effective; volatility in the price of SINTX’s common stock; the uncertainties inherent in new product development, including the cost and time required to commercialize such product(s); market acceptance of our products once commercialized; SINTX’s ability to raise additional funding and other competitive developments. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations, and beliefs. There can be no assurance that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 22, 2021, and in SINTX’s other filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report. Business Inquiries for SINTX:SINTX Technologies801.839.3502IR@sintx.com Media Inquiries for SINTX: Amanda Barry Associate Director, Content and PR The Summit Group abarry@summitslc.com

  • SINTX Technologies announces a fabric technology shown to inactivate upon contact SARS-CoV-2, the virus causing the COVID-19 pandemic
    GlobeNewswire

    SINTX Technologies announces a fabric technology shown to inactivate upon contact SARS-CoV-2, the virus causing the COVID-19 pandemic

    Silicon nitride-embedded fabrics proved effective against inactivating SARS-CoV-2 virusThe fabrics may be suitable for many applications, including masks, surgical gowns, and air filters -----------Salt Lake City, UT, March 09, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies (www.sintx.com) (“SINTX”; “the Company”) a company that develops and commercializes silicon nitride for multiple applications, today announced test results showing that fabrics containing SINTX’s silicon nitride continue to demonstrate inactivation of the SARS-CoV-2 virus upon contact. Earlier tests had shown that sintered silicon nitride powders reduced viral loads by as much as 99.9%, starting at one minute after exposure to silicon nitride. “Last year we announced that our R&D team bonded silicon nitride particles consistently and evenly into the fibers of a nonwoven fabric layer,” said Dr. Sonny Bal, CEO and President of SINTX. “We now have results on tests done at the University of Rochester, New York, which show that these fabrics containing silicon nitride had comparable efficacy against inactivation of the SARS-CoV-2 virus upon contact as silicon nitride alone.” The Company expects the antiviral fabrics to be used in many applications, such as a “catch-and-kill” face mask, surgical gowns and drapes, automotive and HVAC filters, wound dressings, clothing, and more. SINTX believes that products made of its fabrics will inactivate trapped pathogens and reduce the risk of disease transmission. “Our new fabric-based R&D may improve the effectiveness of PPE,” said Bryan McEntire, Ph.D., Chief Scientific Officer at SINTX. “Currently available face masks, for example, that make antiviral claims rely on the addition of metal ions, such as silver, copper, and zinc, as well as other chemicals to the mask fabrics. Unlike these additives, which are either allergenic or toxic to human tissue, extensive testing has shown that silicon nitride powder is non-allergenic, and non-toxic to mammalian cells. Additional development and testing will continue with the goal of meeting ISO and ASTM standards in the forthcoming months.” SINTX continues to develop manufacturing processes to scale up the production of silicon nitride-embedded fabrics for applications across a variety of different markets. SINTX believes the development of silicon nitride embedded fabrics can help fulfill the global need for masks and other antiviral applications around the world. About SINTX Technologies, Inc.SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. The company presently manufactures silicon nitride powders and components in its FDA registered, ISO 9001:2015 certified, ISO 13485:2016 certified, and AS9100D certified manufacturing facility. For more information on SINTX Technologies or its silicon nitride material platform, please visit www.sintx.com. Forward-Looking StatementsSINTX Technologies: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA) that are subject to a number of risks and uncertainties. These risks and uncertainties include, but are not limited to silicon nitride-containing masks not showing the same results as those obtained with silicon nitride during laboratory testing. End-user products containing silicon nitride may or may not show the same properties as the material itself. New product development entails inherent uncertainties and risks, including but not limited to the cost- and time-prohibitive barriers toward product commercialization, lack of market acceptance of such products, and regulatory barriers that may prove insurmountable. Forward-looking statements speak only as of the date on which they are made, and reflect management’s best estimates, projections, expectations, and beliefs, with no assurances or guarantees of future results. Risks and uncertainties are disclosed in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 26, 2020, and in SINTX’s other filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements, and undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report. Business Inquiries for SINTX:SINTX Technologies 801.839.3502 IR@sintx.com Media Inquiries for SINTX: Amanda Barry Associate Director, Content and PR The Summit Groupabarry@summitslc.com